MindRank
Click to visit website
About
MindRank is a clinical-stage biotechnology company that leverages artificial intelligence to revolutionize the discovery and development of small molecule drugs. By integrating advanced machine learning techniques with deep expertise in biology and chemistry, the company aims to overcome the traditional bottlenecks of the pharmaceutical industry. Its primary mission is to identify better therapeutic candidates more efficiently, ultimately expanding the range of treatable diseases and improving patient outcomes globally through accelerated development cycles. The company's approach is centered on proprietary AI platforms that facilitate "Design as a Service" (DaaS) and internal pipeline development. A standout example of their capability is MDR-001, an oral small-molecule GLP-1 RA designed for treating obesity and type 2 diabetes. This drug candidate moved from program initiation to US IND approval in just 19 months, a timeframe significantly shorter than industry averages. The platform excels at navigating complex chemical spaces to find viable leads for challenging or "hard-to-drug" molecular targets that traditional methods often fail to address. MindRank serves a diverse range of stakeholders within the life sciences ecosystem. It is particularly well-suited for pharmaceutical companies looking to outsource drug design through its DaaS model, as well as academic institutions and biotech firms seeking collaborative development opportunities. Their innovations are supported by a strong foundation of scientific validation, with findings frequently published in high-impact journals such as Nature and Cell Press. This commitment to peer-reviewed science ensures that their AI-driven methodology is grounded in rigorous biological and chemical principles. What sets MindRank apart is its proven track record in moving AI-designed molecules into late-stage clinical trials. While many AI drug discovery tools remain theoretical or in early discovery phases, MindRank has successfully transitioned candidates like MDR-001 into Phase III clinical trials. Furthermore, the company maintains a global presence with research hubs in London, Shanghai, and Hangzhou, supported by a network of prestigious academic partners like the University of Cambridge, Imperial College London, and Duke University.
Pros & Cons
Demonstrated success moving an AI-designed drug (MDR-001) to Phase III clinical trials.
Significant reduction in development timelines, achieving US IND approval in just 19 months.
Strong academic network including partnerships with the University of Cambridge and Imperial College London.
Specialized focus on hard-to-drug targets that often lack viable therapeutic candidates.
Global presence with research hubs in the UK and China providing diverse scientific expertise.
No publicly available self-service software platform for independent researchers or small labs.
The primary focus on small molecules may exclude researchers working on biologics or gene therapies.
Limited public information regarding the specific machine learning architectures used in the platform.
Use Cases
Pharmaceutical companies can utilize the Design as a Service model to outsource the discovery of small molecule candidates for specific disease targets.
Biotech startups can partner with MindRank to co-develop innovative therapies, leveraging an AI platform to reduce R&D costs and time-to-market.
Clinical researchers can access a pipeline of AI-optimized drug candidates for Phase II and Phase III trials in obesity and diabetes treatment.
Platform
Task
Features
• multi-disciplinary ml integration
• clinical-stage pipeline management
• ind filing acceleration
• lead optimization
• hard-to-drug target identification
• small molecule drug discovery
• design as a service (daas)
• proprietary ai platforms
FAQs
What is MindRank's primary focus in drug discovery?
MindRank focuses on using AI to discover small molecule drugs, specifically targeting "hard-to-drug" molecular targets. Their research is currently centered on metabolic diseases like obesity and type 2 diabetes.
How fast is MindRank's drug discovery process?
The company has demonstrated the ability to move from program initiation to US IND approval in 19 months. This was specifically achieved with their proprietary drug candidate, MDR-001.
Does MindRank offer services to external partners?
Yes, MindRank provides a "Design as a Service" (DaaS) model for external organizations. They also engage in co-development partnerships and wholly owned pipeline projects.
Where are MindRank's research facilities located?
MindRank operates globally with offices and research centers in London, Shanghai, and Hangzhou. This allows them to collaborate with international partners and top-tier academic institutions.
What kind of drug targets does the platform handle?
The platform is designed to handle difficult or "hard-to-drug" molecular targets. By integrating machine learning with chemistry and biology, it finds pathways that traditional methods might miss.
Pricing Plans
Enterprise & Partnerships
Unknown Price• Proprietary AI platform access
• Design as a Service (DaaS)
• Co-development opportunities
• Target identification
• Lead optimization
• IND filing support
• Clinical trial candidate access
Job Opportunities
There are currently no job postings for this AI tool.
Ratings & Reviews
No ratings available yet. Be the first to rate this tool!
Alternatives
X-Chem
X-Chem accelerates small molecule drug discovery by combining DEL technology with AI solutions. Their ArtemisAI platform powers HITMiner for molecular interaction mapping and hit expansion.
View Details
BenevolentAI
BenevolentAI uses AI for drug discovery and development, partnering with pharma companies to tackle complex diseases and accelerate drug development timelines.
View Details
Aitia Bio
Aitia Bio uses AI, multi-omic data, and Gemini Digital Twins to accelerate drug discovery and development, focusing on oncology and neurodegenerative diseases.
View Details
Aganitha AI
Aganitha AI is an in silico company that partners with biopharma, personal & homecare, and material sciences industries, leveraging AI to accelerate scientific R&D.
View Details
Delta4
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
View Details
ALS.ai
Accelerate ALS drug discovery and target identification using deep generative models and multi-omics data analysis to find novel therapeutics for patients.
View Details
canSAR.ai
canSAR.ai is an integrated knowledge-base leveraging machine learning and AI for cancer drug discovery and translational research worldwide.
View Details
Phenomic AI
Identify novel therapeutic targets for hard-to-treat solid tumors by using an ML-powered transcriptomics platform to analyze single-cell RNA and stromal biology.
View Details
biotx.ai
Help pharmaceutical researchers accelerate drug discovery and minimize clinical trial failure by mapping causal genetic links using AI-driven Mendelian randomization.
View Details
Proxima
Design programmable protein interactions and discover next-generation proximity-based medicines using an integrated AI platform for biopharmaceutical research.
View Details
Iktos
Accelerate drug discovery by integrating generative AI with automated robotics to design, synthesize, and test novel molecules in under two years for pharma teams.
View Details
Atomic AI
Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.
View Details
Iambic
Design superior therapeutic molecules and accelerate drug discovery using physics-based AI algorithms and high-throughput experimental feedback loops.
View Details
GSK.ai
Accelerate drug discovery and vaccine development by leveraging AI to interpret complex genetic datasets and understand the fundamental language of human cells.
View Details
Cognit
Accelerate functional genomics research and simulate complex gene regulatory networks using cross-species foundational AI models for in-silico cell engineering.
View Details
Gero
Extend healthy human lifespan and discover novel therapeutic targets using physics-informed AI models trained on over 100 million longitudinal medical records.
View Details
Receptor.AI
Optimize early-stage drug discovery for biotech researchers using an AI ecosystem that identifies cryptic binding sites and predicts over 80 ADMET endpoints.
View Details
Wisecube
Accelerate life sciences R&D using a foundational graph AI that unifies billions of biomedical data points to provide reliable, literature-backed insights.
View Details
Pending AI
Empower drug discovery teams to unlock difficult-to-drug targets and optimize lead candidates using quantum mechanical precision and trillion-scale generative AI.
View DetailsFeatured Tools
adly.news
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
View Details
Atoms
Launch full-stack products and acquire customers in minutes using a coordinated team of AI agents that handle everything from deep research to SEO and coding.
View Details
Reztune
Land more interviews by instantly tailoring your resume to any job description using AI-driven keyword optimization and professional, ATS-friendly templates.
View Details
Image to Image AI
Transform photos and videos using advanced AI models for face swapping, restoration, and style transfer. Perfect for creators needing fast, professional visuals.
View Details
Nano Banana
Edit and enhance photos using natural language prompts while maintaining character consistency and scene structure for professional marketing and digital art.
View Details
Nana Banana Pro
Maintain perfect character consistency across diverse scenes and styles with advanced AI-powered image editing for creators, marketers, and storytellers.
View Details
Kling 4.0
Transform text and images into cinematic 1080p videos with multi-shot storytelling, character consistency, and native lip-synced audio for professional creators.
View Details
AI Seedance
Generate 15-second cinematic 2K videos with physics-based audio and multi-shot narratives from text or images. Ideal for creators and marketing teams.
View Details
Mistrezz.AI
Engage in immersive NSFW roleplay and ASMR voice sessions with adaptive AI companions designed for structured escalation, fantasy scenarios, and personal connection.
View Details
Seedance 3.0
Transform text prompts or static images into professional 1080p cinematic videos. Perfect for creators and marketers seeking high-quality, physics-aware AI motion.
View Details
Seedance 3.0
Transform text descriptions into cinematic 4K videos instantly with ByteDance's advanced AI, offering professional-grade visuals for creators and marketing teams.
View Details